Mereo BioPharma Group
(MREO)
undefined
undefined%
At close: undefined
3.76
1.21%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Net Income | -29.47M | -36.09M | 14.24M | -166.45M | -41.12M | -37.31M | -46.95M | -33.72M |
Depreciation & Amortization | 1.06M | 727.00K | 642.00K | 1.60M | 1.58M | 37.80K | 36.08K | 32.94K |
Stock-Based Compensation | 4.92M | 4.77M | 4.46M | 2.12M | 1.64M | 2.19M | 3.65M | 6.49M |
Other Working Capital | -786.00K | 1.13M | -1.26M | -3.55M | -6.73M | - | - | - |
Other Non-Cash Items | 3.94M | -9.14M | 13.41M | 5.22M | -429.00K | 1.92M | 751.65K | 179.76K |
Deferred Income Tax | - | - | -34.99M | 133.14M | 69.00K | 7.62M | 7.34M | 1.60M |
Change in Working Capital | -1.59M | 1.82M | -1.84M | -3.41M | -7.67M | 2.41M | 3.02M | -1.99M |
Operating Cash Flow | -21.13M | -38.82M | -5.24M | -28.34M | -45.93M | -23.14M | -32.15M | -27.40M |
Capital Expenditures | -419.00K | -10.00K | -535.00K | -16.00K | -21.00K | -35.54K | -2.30M | -3.47K |
Acquisitions | - | - | - | -354.00K | 10.07M | - | - | - |
Purchase of Investments | - | - | - | - | - | - | -2.50M | - |
Sales Maturities Of Investments | - | - | - | - | 32.87M | - | - | - |
Other Investing Acitivies | -419.00K | 1.51M | 114.00K | 1.86M | 377.00K | 287.09K | 1.05M | 376.08K |
Investing Cash Flow | -419.00K | 1.50M | -421.00K | 1.50M | 43.30M | 251.56K | -3.74M | 372.61K |
Debt Repayment | -3.19M | -1.13M | -933.95K | 30.65M | -2.90M | 577.35K | 27.03M | 4.27M |
Common Stock Repurchased | - | - | - | - | -1.31M | -306.84K | - | - |
Dividend Paid | - | - | - | - | - | - | - | - |
Other Financial Acitivies | -444.00K | 349.96K | -253.73K | -23.35M | -2.50M | -2.61M | -1.70M | -3.70M |
Financial Cash Flow | 7.97M | -784.00K | 77.65M | 34.74M | -5.71M | -2.07M | 33.74M | 68.36M |
Net Cash Flow | -10.76M | -37.96M | 70.83M | 7.12M | -8.70M | -25.00M | -3.53M | 41.33M |
Free Cash Flow | -21.55M | -38.83M | -5.77M | -28.36M | -45.95M | -23.17M | -34.44M | -27.40M |